leucine has been researched along with Chondrodysplasia Punctata, Rhizomelic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brites, P; Distel, B; Heijmans, HS; Hettema, E; Hogenhout, E; Motley, A; Tabak, HF; Wanders, RJ; Wijburg, F | 1 |
1 other study(ies) available for leucine and Chondrodysplasia Punctata, Rhizomelic
| Article | Year |
|---|---|
Molecular basis of rhizomelic chondrodysplasia punctata type I: high frequency of the Leu-292 stop mutation in 38 patients.
Topics: Chondrodysplasia Punctata, Rhizomelic; Gene Frequency; Humans; Leucine; Mutation; Peroxisomal Targeting Signal 2 Receptor; Receptors, Cytoplasmic and Nuclear | 1998 |